Expression of p27Kip1, A Cell Cycle Repressor Protein with Dual Roles for Both Cancer Prevention and Promotion, Is Regulated Primarily at the Level of Unusual p27Kip1 mRNA—A Short Concept Proposal
- 1 Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA
- 2 Webb Nutrition Sciences Building, University Boulevard, Birmingham, AL, USA
Abstract
The p27Kip1 is a cell cycle repressor protein that regulates primarily the cell cycle transition from G1 to S phase and hence the DNA replication is in the S phase and cell division in the M phase. Expression of p27Kip1 protein has dual roles for both cancer prevention and promotion. For example, numerous nutritional and chemopreventive anti-cancer agents specifically increase the expression of p27Kip1 protein without directly affecting the expression of any other cell cycle regulatory proteins. On the other hand, pro-cancer agents (like glucose, insulin and other growth factors frequently seen in obesity and/or diabetes) specifically decrease the expression of p27Kip1 protein without directly affecting the expression of any other cell cycle regulatory proteins. Unlike expression of any other cell cycle regulatory proteins, expression of p27Kip1 protein is very unusual. The mRNA of p27Kip1 has a very long and unusual 5’-untranslated region (from - 575 to -1 in human). It appears that the 5’-untranslated region of p27Kip1 mRNA forms two alternative secondary structures . One increases the expression of p27Kip1 protein when anti-cancer agents are added and another decrease the expression of p27K1p1 when pro-cancer agents are added. For this short concept proposal, Dr. Albert Einstein’s “visualized thought experiments (German: Gedanken experiment) ” were used as a fundamental tool for understanding how either anti- or pro-cancer agents bring the primary structure of the 5’-untranslated region of p27Kip1 mRNA into two alternative secondary structures, thereby either increasing or decreasing, respectively, the translation initiation of p27Kip1 protein.
- Eto (2006) Nutritional and Chemopreventive Anti-Cancer Agents Up-Regulate Expression of p27Kip1, a Cyclin-Dependent Kinase Inhibitor, in Mouse JB6 Epidermal and Human MCF7, MDA-MB-321 and AU565 Breast Cancer Cells. Cancer Cell International, 6, 2. https://doi.org/10.1186/1475-2867-6-2
- Eto (2010) Upstream Molecular Signaling Pathways of p27(Kip1) Expression: EFFECTS of 4-Hydroxytamoxifen, Dexamethasone, and Retinoic Acids. Cancer Cell International, 10, 3. https://doi.org/10.1186/1475-2867-10-3
- Eto (2011) Upstream Molecular Signaling Pathways of p27 (Kip1) Expression in Human Breast Cancer Cells in Vitro: Differential Effects of 4-Hydroxytamoxifen and Deficiency of Either D-(+)-Glucose or L-Leucine. Cancer Cell International, 11, 31. https://doi.org/10.1186/1475-2867-11-31
- Eto (2013) Expression of p27Kip1, a Cell Cycle Repressor Protein, Is Inversely Associated with Potential Carcinogenic Risk in the genetic Rodent Models of Obesity and Long-Lived Ames Dwarf Mice. Metabolism Clinic and Experimental, 62, 873-887. https://doi.org/10.1016/j.metabol.2013.01.001
- Eto (2014) Expression of p27(Kip1), a Cyclin-Dependent Kinase Inhibitor, in Human Peripheral Blood Mononuclear Cells Is Inversely Associated with Potential Carcinogenic Risk in Obese Type 2 Diabetic Individuals Relative to Lean Normal Controls. American Journal of Molecular Biology, 4, 114-128. https://doi.org/10.4236/ajmb.2014.43013